Search

  • Select Article Type
  • Abstract Supplements
  • Blood Group Review
  • Call to Arms
  • Hypothesis
  • In Memoriam
  • Interview
  • Introduction
  • Letter to the Editor
  • Short Report
  • abstract
  • Abstracts
  • Article
  • book-review
  • case-report
  • case-study
  • Clinical Practice
  • Commentary
  • Conference Presentation
  • conference-report
  • congress-report
  • Correction
  • critical-appraisal
  • Editorial
  • Editorial Comment
  • Erratum
  • Events
  • Letter
  • Letter to Editor
  • mini-review
  • minireview
  • News
  • non-scientific
  • Obituary
  • original-paper
  • original-report
  • Original Research
  • Pictorial Review
  • Position Paper
  • Practice Report
  • Preface
  • Preliminary report
  • Product Review
  • rapid-communication
  • Report
  • research-article
  • Research Communicate
  • research-paper
  • Research Report
  • Review
  • review -article
  • review-article
  • review-paper
  • Review Paper
  • Sampling Methods
  • Scientific Commentary
  • short-communication
  • short-report
  • Student Essay
  • Varia
  • Welome
  • Select Journal
  • Polish Journal Of Microbiology
  • In Jour Smart Sensing And Intelligent Systems
  • Advancements Of Microbiology
  • Architecture Civil Engineering Environment
  • Immunohematology
  • Acta Neurobiologiae Experimentalis

 

Article | 30-November-2019

SARS-COV-2 AND BETACORONAVIRUS: WHAT HAVE WE LEARNED IN 8 MONTHS?

(HCoV-NL63) represent the genus Alphacoronavirus. Severe acute respiratory syndrome-related coronavirus 1 (SARS-CoV), Middle East respiratory syndrome-related coronavirus (MERS-CoV), severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), HCoV-HKU-1, and HCoV-OC43 are members of the genus Betacoronavirus. All coronaviruses infecting humans have a zoonotic origin, and bats are most likely the natural hosts for all presently known human CoVs, including SARS-CoV and MERS-CoV viruses [45

Agnieszka Kwiatek, Monika Adamczyk-Popławska

Postępy Mikrobiologii - Advancements of Microbiology, Volume 59 , ISSUE 3, 197–206

Article | 12-October-2020

COVID-19 – DISEASE CAUSED BY SARS-COV-2 INFECTION – VACCINE AND NEW THERAPIES RESEARCH DEVELOPMENT

1. Wprowadzenie Wybuch epidemii wywołany przez SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) powodujący ostry syndrom zapalenia płuc [41] skłania badaczy z wielu krajów do intensywnych badań nad rozpoznaniem biologii, patogenezy oraz dróg transmisji tego wirusa. Trwają intensywne prace zmierzające do opracowania szczepionki, a także poszukiwania nowych leków stosowanych osobno lub w kombinacji, które mogłyby być skuteczne w zwalczaniu objawów choroby nazwanej według zaleceń WHO

Elżbieta Nowakowska, Sylwia Sulimiera Michalak

Postępy Mikrobiologii - Advancements of Microbiology, Volume 59 , ISSUE 3, 227–236

Article | 24-March-2021

NOVEL SARS-COV-2 PANDEMIC TRANSMISSION WITH ONGOING ANTIVIRAL THERAPIES AND VACCINE DESIGN

failure and acute pneumonia in its first patient from Saudi Arabia in 2012. That virus infected 2494 people with 858 deaths reported from 27 countries with a case fatality rate (CFR) of 34.4%. SARS-CoV caused respiratory failure in patients firstly recognized and reported from China and infected 8422 people with 919 deaths from 32 countries between November 2012 and August 2013 with CFR of 11% [41]. Emerging at the end of 2019 in Wuhan, China, SARS-CoV-2 was initially recognized as a pneumonia-causing

Muhammad Yameen, Sara Sattar, Ayesha Khalid, Muhammad Aamir Aslam, Nishat Zafar, Muhammad Hassan Saeed, Muhammad Haseeb Arif, Muhammad Jahangeer, Azka Qadeer, Shoukat Hussain, Muhammad Aamir, Sania Mukhtar, Huma Nasir, Asif Shahzad

Postępy Mikrobiologii - Advancements of Microbiology, Volume 60 , ISSUE 1, 13–20

short-communication | 17-September-2021

Discovery and Full Genome Characterization of SARS-CoV-2 in Stool Specimen from a Recovered Patient, China

The recent emergence of a novel coronavirus (SARS-CoV-2) in China was associated with severe human infection and has emerged globally as a highly virulent human pathogen, causing severe public health concerns (Holshue et al. 2020; Zhu et al. 2020). Currently, the virus transmission is considered the following two main routes: respiratory droplets and contact (To et al. 2020). To fortify the response against the alarming levels of spread of the virus, many countries have tightened the detection

YONGDONG LI, YI CHEN, HONGXIA NI, BO YI, DANDAN ZHANG, JIANING ZHANG, WENJING WANG, YUHUI LIU, SULI JIAO, GUOZHANG XU, WEIDONG QIAN

Polish Journal of Microbiology, Volume 70 , ISSUE 3, 401–404

Article | 30-November-2019

COVID-19 THERAPY: WHAT HAVE WE LEARNED IN 8 MONTHS?

SARS-CoV-2 in December 2019 in Wuhan (Hubei province, China) marked the next introduction of a novel, highly pathogenic CoV into the human population [112]. In most cases, SARS-CoV-2 causes mild or moderate respiratory illness and the recovery does not require any special treatment. However, some infected individuals, with associated medical conditions, developed a severe disease called Coronavirus Disease 2019 (COVID-19) with such clinical manifestations as dyspnea, hypoxia, and lung lesions

Monika Adamczyk-Popławska, Agnieszka Kwiatek

Postępy Mikrobiologii - Advancements of Microbiology, Volume 59 , ISSUE 3, 207–225

review-article | 26-March-2021

Putative mechanism of neurological damage in COVID-19 infection

INTRODUCTION The appearance of the novel coronavirus (SARS--CoV-2) in late 2019, took the whole world by surprise. It was first observed in Wuhan, Hubei Province, China, but quickly spread across the globe reaching the classification of pandemic by the World Health Organization (WHO). The location of the SARS-CoV-2 outbreak could have been at the Huanan seafood market because the origin of the initial cases showed a history of direct or indirect contact there. The virus was first isolated from

Cindy Bandala, José Luis Cortes-Altamirano, Samuel Reyes-Long, Eleazar Lara-Padilla, Ian Ilizaliturri-Flores, Alfonso Alfaro-Rodríguez

Acta Neurobiologiae Experimentalis, Volume 81 , ISSUE 1, 69–79

research-article | 30-November-2020

An overview of technologies and devices against COVID-19 pandemic diffusion: virus detection and monitoring solutions

In this research work, different innovative systems will be proposed for the detection of SARS-CoV-2. The SARS-CoV-2 virus consists of four structural proteins, namely, spike (S), envelope (E), membrane (M), and nucleocapsid (N). The name coronavirus is due to the presence of spike glycoproteins S (the S1 subunit and the S2 subunit) on its surface/envelope, just like a crown. Since the end of 2019, the COVID-19 virus has spread widely all over the world. In this field, the technology offers

R. de Fazio, A. Sponziello, D. Cafagna, R. Velazquez, P. Visconti

International Journal on Smart Sensing and Intelligent Systems, Volume 14 , ISSUE 1, 1–28

Article | 10-April-2021

An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay

The coronavirus disease 2019 (COVID-19) pandemic continues to cause significant morbidity and mortality, place unprecedented challenges on health care systems, and affect the global economy. Early efforts to diagnose and treat COVID-19 largely relied on nucleic acid testing and basic supportive care. Among treatment options considered early in the pandemic, convalescent plasma (CP) therapy quickly emerged as a potential strategy to combat the new SARS-CoV-2 pathogen.1 Despite conflicting data

A.D. Ho, H. Verkerke, J.W. Allen, B.J. Saeedi, D. Boyer, J. Owens, S. Shin, M. Horwath, K. Patel, A. Paul, S.-C. Wu, S. Chonat, P. Zerra, C. Lough, J.D. Roback, A. Neish, C.D. Josephson, C.M. Arthur, S.R. Stowell

Immunohematology, Volume 37 , ISSUE 1, 33–43

research-article | 25-June-2021

CORONAVIRUSES – HOW PROTEIN INTERACTIONS CHANGED OUR PERCEPTION OF THE WORLD

1. Wprowadzenie Na przełomie 2019 i 2020 roku uwaga mieszkańców całego świata skierowana została na nowego koronawirusa nazwanego SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) wywołującego epidemię zapalenia płuc COVID-19 (CoronaVIrus Disease 19), który pojawił się w prowincji Wuhan w centralnych Chinach. W niedługim czasie wirus opanował ludność całego świata i w marcu 2020 roku Światowa Organizacja Zdrowia ogłosiła COVID-19 pandemią. SARS-CoV-2 jest trzecim w XXI wieku

Jolanta Bratosiewicz-Wąsik, Tomasz J. Wąsik

Advancements of Microbiology – Postepy Mikrobiologii, Volume 60 , ISSUE 2, 121–135

research-article | 30-November-2019

COVID-19 AND LIBRARY PUBLIC SPACE TRANSFORMATIONS

the current state of affairs are no longer enough. As the crisis drags on and takes on a permanent character, it seems necessary to consider the problem of cultural integration of public library spaces in urban systems of the world with COVID-19 more broadly. The present study aims to determine the content of transformations of library spaces due to the spread of the SARS-CoV-2 coronavirus and to identify directions for further spatial changes in library spaces under new pandemic conditions. The

Nadiia ANTONENKO, Tetiana RUMILETS

Architecture, Civil Engineering, Environment, Volume 13 , ISSUE 4, 5–18

No Record Found..
Page Actions